Skip to content
CA.gov logo in white
  • Grants Management System
  • CIRM Hub Portal
  • Contact
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Strategic Goals
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • CIRM Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Strategic Goals
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • CIRM Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops

Cellular tools to study brain diseases affecting synaptic transmission

  • Post author:
  • Post published:January 21, 2026
  • Post category:

There is a group of brain diseases that are caused by functional abnormalities. The brains of patients afflicted with these diseases which include autism spectrum disorders, schizophrenia, depression, and mania…

Continue ReadingCellular tools to study brain diseases affecting synaptic transmission

Use of iPS cells (iPSCs) to develop novels tools for the treatment of spinal muscular atrophy.

  • Post author:
  • Post published:January 21, 2026
  • Post category:

Spinal Muscular Atrophy (SMA) is one of the most common lethal genetic diseases in children. One in thirty five people carry a mutation in a gene called survival of motor…

Continue ReadingUse of iPS cells (iPSCs) to develop novels tools for the treatment of spinal muscular atrophy.

Use of hiPSCs to develop lead compounds for the treatment of genetic diseases

  • Post author:
  • Post published:January 21, 2026
  • Post category:

This study will use Ataxia-Telangiectasia (A-T), an early-onset inherited neurodegenerative disease of children, as a model to study the mechanisms leading to cerebellar neurodegeneration and to develop a drug that…

Continue ReadingUse of hiPSCs to develop lead compounds for the treatment of genetic diseases

Development of small molecule screens for autism using patient-derived iPS cells

  • Post author:
  • Post published:January 21, 2026
  • Post category:

Autism Spectrum Disorders (ASDs) are a heritable group of neuro-developmental disorders characterized by language impairments, difficulties in social integrations, and the presence of stereotyped and repetitive behaviors. There are no…

Continue ReadingDevelopment of small molecule screens for autism using patient-derived iPS cells

Pluripotent and Somatic Stem Cell Models to Study Inherited Diarrheal Disorders

  • Post author:
  • Post published:January 21, 2026
  • Post category:

Our research group at [REDACTED] has had a long-standing interest in understanding the cause of several disorders that result in severe, and often times fatal forms of diarrhea in children.…

Continue ReadingPluripotent and Somatic Stem Cell Models to Study Inherited Diarrheal Disorders

Inhibitory Nerve Cell Precursors: Dosing, Safety and Efficacy

  • Post author:
  • Post published:January 21, 2026
  • Post category:

Many neurological disorders are characterized by an imbalance between excitation and inhibition. Our ultimate goal: to develop a cell-based therapy to modulate aberrant brain activity in the treatment of these…

Continue ReadingInhibitory Nerve Cell Precursors: Dosing, Safety and Efficacy

Stem Cell Therapy for Duchenne Muscular Dystrophy

  • Post author:
  • Post published:January 21, 2026
  • Post category:

Duchenne muscular dystrophy (DMD) is the most common and serious form of muscular dystrophy. One out of every 3500 boys is born with the disorder, and it is invariably fatal.…

Continue ReadingStem Cell Therapy for Duchenne Muscular Dystrophy

Developing a therapeutic candidate for Canavan disease using induced pluripotent stem cell

  • Post author:
  • Post published:January 21, 2026
  • Post category:

Canavan disease is a devastating disease of infants which affects their neural development and leads to mental retardation and early death. It occurs in 1 in 6,400 persons in the…

Continue ReadingDeveloping a therapeutic candidate for Canavan disease using induced pluripotent stem cell

New Drug Discovery for SMA using Patient-derived Induced Pluripotent Stem Cells

  • Post author:
  • Post published:January 21, 2026
  • Post category:

Spinal muscular atrophy (SMA) is the leading genetic cause of infant death in the U.S. This devastating disease affects 1 child in every 6,000-10,000 live births, with a North American…

Continue ReadingNew Drug Discovery for SMA using Patient-derived Induced Pluripotent Stem Cells

Developing a drug-screening system for Autism Spectrum Disorders using human neurons

  • Post author:
  • Post published:January 21, 2026
  • Post category:

Autism and autism spectrum disorders (ASD) are complex neurodevelopmental diseases that affect 1 in 150 children in the United States. Such diseases are mainly characterized by deficits in verbal communication,…

Continue ReadingDeveloping a drug-screening system for Autism Spectrum Disorders using human neurons
  • Go to the previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 8
  • Go to the next page
  • Careers
  • Administrative & Financials
  • Accessibility

Subscribe to Receive CIRM News

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox. 

Sign Up
Facebook-f X-twitter Instagram Linkedin Youtube
  • Privacy Policy
  • ©2025 California Institute for Regenerative Medicine
  • Media Guidelines
  • Contact Us